Delivery Order 75N93024D00013-75N93026F00001

Award Date 9/25/26

Potential Completion Date 7/14/31

Potential Value $333K

Federal Agency

National Institute of Allergy and Infectious Diseases

Awardee

Institute For Clinical Pharmacodynamics, Inc. Z82HHPY83MC7

Ultimate Awardee

Not listed

NAICS Category

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

PSC Category

AN11 - Health R&D Services; Health Care Services; Basic Research

Federal Contract Vehicle

Pre-Clinical Models of Infectious Diseases

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Schenectady, NY 12305, USA

Solicitation Procedures

Multiple Award, Fair Opportunity

Number Of Offers Received

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The National Institute of Allergy and Infectious Diseases issued a delivery order to Institute For Clinical Pharmacodynamics, Inc. on September 25, 2026, under the Pre-Clinical Models of Infectious Diseases IDIQ for pharmacokinetic-pharmacodynamic analysis of mouse model efficacy and PK data for antibacterial compounds. The order carries a ceiling value of $333,240.

Place of performance is Schenectady, NY. The order runs through July 14, 2031. Work encompasses pre-clinical models of infectious diseases, including animal model studies, pathogen production and characterization, and evaluation of candidate countermeasures. Pricing is firm fixed price. Institute For Clinical Pharmacodynamics, Inc. is minority-owned.

Generated 9/26/26, 10:04 AM